These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 12404911)

  • 1. [Deterioration of schizoaffective disorder due to an interaction between haloperidol and carbamazepine].
    Cohen D; Diemont WL
    Ned Tijdschr Geneeskd; 2002 Oct; 146(41):1942-4. PubMed ID: 12404911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Deterioration of schizoaffective disorder due to an interaction between haloperidol and carbamazepine].
    Schalekamp T
    Ned Tijdschr Geneeskd; 2003 Feb; 147(8):365; author reply 365. PubMed ID: 12661128
    [No Abstract]   [Full Text] [Related]  

  • 3. [Deterioration of schizoaffective disorder due to an interaction between haloperidol and carbamazepine].
    Le Comte M; Wensveen B; Kreutzkamp T
    Ned Tijdschr Geneeskd; 2003 Jun; 147(26):1293. PubMed ID: 12861673
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of carbamazepine and valproate on haloperidol plasma levels and on psychopathologic outcome in schizophrenic patients.
    Hesslinger B; Normann C; Langosch JM; Klose P; Berger M; Walden J
    J Clin Psychopharmacol; 1999 Aug; 19(4):310-5. PubMed ID: 10440457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deconstructing a medication regimen.
    Preskorn SH
    J Psychiatr Pract; 2008 Mar; 14(2):114-8. PubMed ID: 18360197
    [No Abstract]   [Full Text] [Related]  

  • 6. Prophylaxis of schizoaffective disorder with lithium or carbamazepine: outcome after long-term follow-up.
    Baethge C; Gruschka P; Berghöfer A; Bauer M; Müller-Oerlinghausen B; Bschor T; Smolka MN
    J Affect Disord; 2004 Apr; 79(1-3):43-50. PubMed ID: 15023479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and safety of combination therapy with lithium and risperidone.
    Demling JH; Huang ML; Remmerie B; Mannaert E; Sperling W
    Pharmacopsychiatry; 2006 Nov; 39(6):230-1. PubMed ID: 17124646
    [No Abstract]   [Full Text] [Related]  

  • 8. Carbamazepine in the treatment of neuroleptic malignant syndrome.
    Thomas P; Maron M; Rascle C; Cottencin O; Vaiva G; Goudemand M
    Biol Psychiatry; 1998 Feb; 43(4):303-5. PubMed ID: 9513741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Catatonic dilemma in a schizoaffective patient with combined lithium-risperidone administration].
    Krähenmann R; Küchenhoff B; Böker H; Schick M
    Psychiatr Prax; 2010 Sep; 37(6):306-9. PubMed ID: 20803411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Open-label steady-state pharmacokinetic drug interaction study on co-administered quetiapine fumarate and divalproex sodium in patients with schizophrenia, schizoaffective disorder, or bipolar disorder.
    Winter HR; DeVane CL; Figueroa C; Ennis DJ; Hamer-Maansson JE; Davis PC; Smith MA
    Hum Psychopharmacol; 2007 Oct; 22(7):469-76. PubMed ID: 17729385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Case report of a possible interaction between neuroleptics and carbamazepine.
    Kanter GL; Yerevanian BI; Ciccone JR
    Am J Psychiatry; 1984 Sep; 141(9):1101-2. PubMed ID: 6147104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Neurotoxicity related to lithium-risperidon combination treatment in a patient with schizoaffective disorder].
    Böker H; Brandenberger M; Schopper C
    Psychiatr Prax; 2007 Jan; 34(1):38-41. PubMed ID: 17106843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monotherapy versus combined treatment with second-generation antipsychotics in bipolar disorder.
    Ketter TA
    J Clin Psychiatry; 2008; 69 Suppl 5():9-15. PubMed ID: 19265635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How long does the pharmacokinetic interaction between carbamazepine and quetiapine last after carbamazepine withdrawal?
    Kopecek M; Potmesil P
    Neuro Endocrinol Lett; 2017 Dec; 38(7):475-478. PubMed ID: 29369597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparative evaluation of clinical and economic effectiveness of preventive therapy of affective and schizoaffective psychoses].
    Ushakov IuV; Kostiukova EG; Kalugina LI; Mirzoian MG
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1990; 90(9):79-82. PubMed ID: 2176049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
    Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J
    Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Lithium intoxication due to simultaneous use of trimethoprim].
    de Vries PL
    Ned Tijdschr Geneeskd; 2001 Mar; 145(11):539-40. PubMed ID: 11284290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluconazole-carbamazepine interaction in a patient with bipolar disorder.
    Tsouli S; Maranis S; Kyritsis AP
    Psychiatry Clin Neurosci; 2011 Feb; 65(1):112. PubMed ID: 21265947
    [No Abstract]   [Full Text] [Related]  

  • 19. Drug-induced systemic lupus erythematosus after 7 years of treatment with carbamazepine.
    Pelizza L; De Luca P; La Pesa M; Minervino A
    Acta Biomed; 2006 Apr; 77(1):17-9. PubMed ID: 16856703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Valproic acid-induced myopathy in a patient with schizoaffective disorder.
    Reiche I; Tröger U; Postel SC; Wolf R; Bode-Böger SM
    J Clin Psychopharmacol; 2009 Aug; 29(4):402-3. PubMed ID: 19593189
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.